Methadone treats opioid addiction by activating the same brain receptors as heroin or fentanyl, but slowly and steadily enough to prevent withdrawal symptoms and cravings without producing the intense high that drives compulsive use. Taken once daily as a liquid or tablet at a regulated clinic, it stabilizes brain chemistry so people can function normally. With a half-life averaging 25 hours, a single dose lasts a full day, which is what makes it effective as a maintenance medication rather than just another opioid.
How Methadone Works in the Brain
Opioids, whether produced naturally by the body or taken as drugs, work by binding to receptors on nerve cells called mu-opioid receptors. When an opioid attaches to these receptors, it triggers a chain reaction: the nerve cell becomes less excitable, pain signals quiet down, and the brain releases a wave of pleasure-related chemicals. Short-acting opioids like heroin flood these receptors all at once, creating a sharp spike of euphoria followed by a crash. That rapid cycle is what makes them so addictive.
Methadone binds to the same receptors but behaves differently. Because it has a slow onset and long duration, it activates the receptors gradually and keeps them occupied for an extended period. This does two important things. First, it prevents withdrawal by keeping nerve cells in a stable state rather than cycling between overstimulation and deprivation. Second, because the receptors are already occupied, other opioids have a diminished effect if someone uses them. The slow, steady activation also means methadone has a reduced impact on mood, judgment, and coordination compared to faster-acting opioids, allowing people to work, drive, and live normally.
What Treatment Looks Like Day to Day
Methadone for opioid use disorder can only be dispensed through federally regulated opioid treatment programs, commonly called methadone clinics. In the early phase, you go to the clinic daily to take your dose under observation. This is partly for safety (the first 72 hours carry the highest risk of breathing problems as your body adjusts) and partly to ensure the dose is correct before you manage it on your own.
As treatment progresses, you can earn take-home doses. Under current federal rules updated in 2024, patients may be eligible for unsupervised doses as early as entry into treatment, based on their provider’s clinical judgment. The criteria include absence of active substance use, regular attendance, no behavioral problems, no diversion activity, and the ability to safely store the medication. The maximum take-home supply scales up: seven days’ worth during the first two weeks, up to 14 days after that, and up to 28 days once you’ve been in treatment for at least 31 days.
Clinics also provide counseling and education, though patient refusal of counseling no longer disqualifies someone from receiving medication. The emphasis has shifted toward making the medication itself as accessible as possible.
How Long People Stay in Treatment
There is no fixed endpoint. Most clinical guidelines recommend staying on methadone for at least a year, and many experts advocate for indefinite maintenance, since the risk of relapse and overdose death rises sharply after stopping. In practice, though, many people leave treatment much sooner.
A large study published in JAMA Network Open found that median treatment duration has been falling. People who started methadone between 2014 and 2016 stayed a median of 193 days (about six and a half months). By 2020 to 2022, that had dropped to just 86 days, under three months. The reasons are complex: some people stop because of side effects or a desire for opioid-free recovery, while others face stigma, transportation barriers, or the burden of frequent clinic visits. Younger adults (ages 15 to 24) and people in lower-income neighborhoods were most likely to discontinue early. People in their mid-40s to early 60s tended to stay longest.
Retention matters because it tracks closely with outcomes. A systematic review of 63 observational studies found a 57% one-year retention rate across opioid substitution programs. People who enter treatment voluntarily tend to stay longer than those who are court-ordered or referred from mandatory residential programs.
Common Side Effects
The most frequent side effects are constipation, sweating, nausea, headache, and decreased sex drive. Constipation is persistent enough that most people need dietary changes or additional medication to manage it. These effects often improve over the first few weeks but can linger for some people throughout treatment.
The most serious risk is slowed breathing, particularly during the first few days or whenever a dose increases. This is why the initial phase is closely supervised. Mixing methadone with alcohol, benzodiazepines, or other sedating substances dramatically increases this danger.
Methadone can also affect heart rhythm by prolonging a specific electrical interval in the heartbeat, known as QT prolongation. This is rare but potentially fatal, and it’s the reason providers monitor heart function, especially at higher doses. Warning signs include a pounding heartbeat, dizziness, or fainting.
Broader Health Benefits
Beyond preventing withdrawal and reducing illicit opioid use, methadone treatment has a significant ripple effect on public health. Because it reduces or eliminates injection drug use, it lowers the transmission of HIV and hepatitis C. One landmark study found a dramatic reduction in new HIV infections among people who entered methadone treatment compared to those who continued injecting heroin. China, which implemented large-scale methadone programs, reported similar reductions in injection-related disease. From a cost perspective, methadone is far cheaper than treating HIV or hepatitis C after the fact.
Overdose deaths involving methadone are also relatively low compared to other opioids. CDC data from 2024 recorded about 3,229 methadone-involved overdose deaths in the United States, a rate of 0.9 per 100,000 people. For comparison, synthetic opioids other than methadone (primarily fentanyl) caused 47,735 deaths that same year, a rate of 14.3 per 100,000. Most methadone-related deaths involve people who obtained it outside a treatment program or combined it with other substances, not patients taking prescribed doses under medical supervision.
How It Compares to Other Treatments
The main alternative medication is buprenorphine (often sold as Suboxone), which works on the same receptors but as a partial activator rather than a full one. Buprenorphine has a ceiling effect, meaning its opioid activity plateaus at a certain dose, which makes it harder to misuse but also less effective for people with very high opioid tolerance. It can be prescribed from a regular doctor’s office, which is a major practical advantage over methadone’s clinic-based model.
Methadone tends to be more effective for people with severe, long-standing opioid dependence, particularly those using fentanyl, because its full activation of the receptors provides more complete relief from cravings and withdrawal. The trade-off is the clinic visits, the stricter regulations, and the greater risk of respiratory depression at high doses. For many people, the choice comes down to severity of dependence, access to a clinic, and how much structure they need in early recovery.